Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-02-26 @ 12:37 AM
Study NCT ID:
NCT02430194
Status:
COMPLETED
Last Update Posted:
2023-03-03
First Post:
2015-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)
Sponsor:
Eiger BioPharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EIG-300-Amendment 3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |